Tilray Brands Q3 Earnings Call Highlights

2 days ago 4

MarketBeat

Wed, April 1, 2026 astatine 10:20 AM CDT 8 min read

Tilray Brands logo

Strong Q3 results: Tilray reported grounds Q3 nett gross of $206.7M (up 11% YoY), gross nett of $55M, adjusted EBITDA of $10.7M (up 19% YoY), narrowed nett nonaccomplishment to $25.2M, and reaffirmed FY2026 adjusted EBITDA guidance of $62–$72M with currency and equivalents of $264.8M.
International and Europe-led growth: Cannabis nett gross roseate 19% to $64.8M driven by a 73% summation successful planetary cannabis sales, portion European organisation (Tilray Pharma) gross grew 35% to $83M, aided by partnerships (Alliance Healthcare, Smartway) and SKU optimization.
Beverage reset and strategical M&A: Beverage gross fell to astir $43M arsenic cost-focused restructuring (Project Four Twenty) delivered savings, and Tilray moved to grow standard via a U.S. licensing woody with Carlsberg (2027) and the post-quarter acquisition of BrewDog IP/assets.
Interested successful Tilray Brands, Inc.? Here are 5 stocks we similar better.

The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations

Tilray Brands (NASDAQ:TLRY) reported grounds third-quarter fiscal 2026 gross and reaffirmed its full-year adjusted EBITDA outlook, arsenic absorption pointed to accelerating planetary cannabis growth, continued advancement successful its European organisation business, and cost-saving efforts successful beverages up of precocious announced strategical moves involving Carlsberg and BrewDog.

Chairman and CEO Irwin Simon said the institution posted “record results” successful the 3rd quarter, with nett gross reaching $207 cardinal and gross nett expanding to $55 cardinal contempt “ongoing manufacture and macroeconomic headwinds.” CFO Carl Merton reported nett gross of $206.7 million, up 11% year-over-year, and said the 4th produced “strong year-over-year improvements successful gross nett and adjusted EBITDA.”

→ Down 25%, Chinese Giant PDD Could Be a Strong Long-Term Value

MarketBeat Week successful Review – 09/29 - 10/03

Tilray’s cannabis nett gross roseate 19% year-over-year to $64.8 million, with Merton attributing the summation to 73% maturation successful gross planetary cannabis gross and 8% maturation successful nett Canadian adult-use and aesculapian cannabis. Simon called the play “the largest 4th ever for planetary cannabis growth,” with planetary cannabis nett income of $24.1 million, up 73% year-over-year and 20% sequentially. He said aesculapian cannabis angiosperm measurement accrued 100% year-over-year and lipid measurement roseate 90%.

Germany, Tilray’s largest planetary market, grew 43% year-over-year, according to Simon, who said the concern overcame astir $7 cardinal successful terms unit that “flows straight to the bottommost line.” Merton besides cited terms compression, noting that planetary pricing reduced planetary cannabis gross by astir $7 cardinal contempt higher gram equivalents sold.

Read Entire Article